Table 1.
Restocking’ of cellular insulin stores (20) |
Recovery of GK activity (21) |
Reduction of gluconeogenic enzymes (e.g., GK, glucose-6-phosphatase, and phosphoenolpyruvate carboxykinase) (23) |
Improved pancreatic islet blood flow (24) |
Decreased islet fibrosis (25) |
Decreased islet antigenicity (26–29) |
Reduction in reactive oxygen species (8, 32, 33) |